Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OCRELIZUMAB vs RITUXIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OCRELIZUMAB vs RITUXIMAB: Safety Overview

Metric OCRELIZUMAB RITUXIMAB
Total FAERS Reports 56,186 178,614
Deaths Reported 1,406 28,910
Death Rate 2.5% 16.2%
Hospitalizations 10,364 54,631
Average Patient Age 47.2 yrs 54.6 yrs
% Female Patients 72.5% 64.3%
Manufacturer Genentech, Inc. Genentech, Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Prescription